EBOO IV Therapy in Phoenix for Advanced Blood Detox & Ozone Therapy

EBOO works through a mechanism called oxidative preconditioning. When therapeutic ozone contacts your blood, it creates controlled, short-lived oxidative signals that activate your body’s endogenous antioxidant systems, particularly the Nrf2 pathway, while simultaneously triggering mitochondrial biogenesis (the creation of new cellular energy factories). The result is a measurable improvement in cellular oxygen utilization, a reduction in chronic inflammatory cytokines, enhanced immune surveillance, and a reset of red blood cell flexibility, which improves microvascular circulation. These effects unfold over hours to days following treatment, which is why most protocols involve a series of sessions.

When performed by a trained clinician using properly calibrated equipment, EBOO has a strong safety profile that has been documented in European medical literature for over two decades. The most common adverse effects are mild: brief fatigue, a detox response in the 24 hours after treatment, or temporary vein discomfort at the IV site. Serious adverse events are rare and are largely preventable through proper pre-treatment screening. EBOO is contraindicated in G6PD deficiency, active hyperthyroidism, uncontrolled bleeding disorders, and in patients on certain anticoagulants. An individualized intake evaluation is always conducted before the first session.

The answer depends significantly on why you are seeking treatment. Healthy patients pursuing longevity optimization often feel meaningful improvement within 2–3 sessions and complete an initial series of 5–10 sessions over 4–8 weeks. Patients managing chronic illnesses like long COVID, Lyme disease, autoimmune conditions, or significant mitochondrial dysfunction typically require a longer induction series of 10–20 sessions, followed by monthly maintenance. Your clinician will recommend a protocol based on your baseline labs, symptom severity, and treatment response, which is reassessed throughout the process.

EBOO is not a treatment for any specific disease in the conventional sense, rather it is a systemic biological intervention that addresses root-level physiological dysfunction. It has been used clinically for chronic fatigue syndrome, post-viral syndromes including long COVID, Lyme disease and co-infections, fibromyalgia, autoimmune conditions, metabolic syndrome, cardiovascular disease risk reduction, chronic infections (including fungal and bacterial), and as a component of oncology supportive care. Its mechanisms, immune modulation, mitochondrial activation, anti-inflammatory signaling, antimicrobial oxygenation, make it broadly applicable to conditions rooted in inflammation, immune dysregulation, or cellular energy failure.

Major Autohemotherapy (MAH) treats 100–200 mL of blood in a single pass with ozone and reinfuses it as a bolus. EBOO surpasses MAH by processing blood in a continuous circuit, treating 3–5 times greater total volume per session. The EBOO Full Spectrum device goes further still by combining ozone therapy with simultaneous ultraviolet blood irradiation (UBI). Different components of blood absorb each type of energy, activating distinct biological pathways that work synergistically. Research shows this combination improves measurable health outcomes by 20–30% over ozone alone, making Full Spectrum EBOO the highest-tier blood therapy protocol currently available in integrative medicine.

EBOO IV therapy is not covered by conventional health insurance, as it is classified as an integrative or experimental procedure by most carriers. As a direct-care practice, we offer transparent, all-inclusive session pricing with no surprise billing. The cost of a single EBOO is $1200. Packages are available at a reduced per-session rate. We encourage you to view EBOO as a precision health investment, one that many of our patients find delivers measurable returns in energy, cognitive function, and reduced sick days that exceed its cost within a few months.

Emerging clinical evidence and extensive practitioner experience suggest that EBOO may be one of the most effective tools currently available for long COVID. The pathophysiology of long COVID involves microclotting and microvascular obstruction, mitochondrial dysfunction, viral antigen persistence, and chronic immune activation, all of which fall within the therapeutic targets of EBOO. Improved red blood cell deformability restores microvascular flow. Mitochondrial activation addresses the profound energy deficit. Immune modulation reduces the chronic inflammatory state. While large randomized controlled trials are ongoing, clinical outcomes in long COVID patients treated with EBOO have been notably encouraging.

Preparation is straightforward but important for optimizing your response. Arrive well-hydrated by starting to hydrate the day before your appointment. In the two hours leading up to your appointment, drink at least 32–40 ounces of water. Eat a protein, fat, and carbohydrate containing meal 1–2 hours prior rather than arriving fasted. Avoid caffeine on the morning of treatment if you are sensitive to it. Wear comfortable, loose-fitting clothing with easy access to the antecubital (inner elbow) area. After your session, continue hydrating, avoid alcohol and strenuous exercise for the rest of the day, and prioritize a nutrient-dense meal. Most patients resume normal activity the following morning.

Ozone therapy, including EBOO, occupies a specific regulatory space in the United States. The FDA has not approved ozone as a drug or treatment, and it does not have a formal IND approval pathway for systemic ozone therapies. However, ozone therapy is legal when practiced within the scope of a licensed medical provider and within state-specific medical practice laws. Our Phoenix practitioners are fully licensed, trained in medical ozone therapy, and operate within all applicable regulatory guidelines. We are transparent about the current state of the evidence and help you make informed decisions.

The placement of the IV line involves the same brief discomfort as any blood draw. Once the circuit is established, the procedure itself is generally well-tolerated and often described as deeply relaxing. Many patients notice a gentle warmth at the IV site, a mild flush sensation, or a feeling of increased clarity and energy within the first 20–30 minutes of treatment. Some patients with significant toxic burden or systemic inflammation may experience a mild Herxheimer-type response like fatigue, mild headache, or flu-like sensation in the hours following treatment. This is a recognized detoxification response, not a side effect, and typically resolves within 24 hours.